CannaPharmaRx makes three board appointments
This article was originally published in Scrip
CannaPharmaRx, a New Jersey-based pharmaceutical company, has expanded its board of directors by three with the express intent of bringing new and diverse skill sets to complement its current board's make-up. New directors include: Dr Alex Giaquinto, Elie Khalife, and Steven Rule.
You may also be interested in...
In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind the 2020 deals with Bicycle Therapeutics and Nimble Therapeutics. She gives insight into how deal makers are shifting gears to make deals happen in the challenging environment of the global coronavirus pandemic.
As the COVID-19 pandemic escalates, companies across the world are preparing to roll out commercial test kits for the detection of SARS-CoV-2.
Biopharmaceutical companies doubled-down on rare disease treatments during the last five years, thanks to a potent combination of scientific discovery and appealing business incentives.